In November 2000, Synthetic Genetics Inc was acquired by SBIR firm, Epoch Biosciences, Inc. of Washington. Producer of biotech genetic engineering systems and provider of biotechnology R&D services. The company specializes in producing synthesized DNA and large scale synthesized reagents; and providing research and development services of therapeutic and diagnostic DNA. This company was capitalized by private investment.